EP Patent

EP4218725B1 — Formulation for soft anticholinergic analogs

Assigned to Bodor Laboratories Inc · Expires 2026-03-11 · 0y expired

What this patent protects

Patent listed against Ecclock.

Drugs covered by this patent

Ecclock (SOFPIRONIUM BROMIDE) · Kaken Pharmaceutical

Patent Metadata

Patent number: EP4218725B1
Jurisdiction: EP
Classification: —
Expires: 2026-03-11
Drug substance claim: No
Drug product claim: No
Assignee: Bodor Laboratories Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.